Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Risa Ebina-Shibuya

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Respiratory Investigation|March 22, 2023
Reply to letter to the editor "antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment"Daisuke Narita, Risa Ebina-Shibuya
Nature Reviews. Immunology|June 1, 2022
Role of thymic stromal lymphopoietin in allergy and beyondRisa Ebina-Shibuya, Warren J Leonard
Clinical and Translational Medicine|May 11, 2023
TSLP-targeting therapy: Beyond allergy?Risa Ebina-Shibuya, Warren J Leonard
Nature Reviews. Immunology|September 24, 2024
Publisher Correction: Role of thymic stromal lymphopoietin in allergy and beyondRisa Ebina-Shibuya, Warren J Leonard
Respirology (Carlton, Vic.)|June 20, 2020
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, et al.
Clinical and Experimental Vaccine Research|September 1, 2020
Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, et al.
The Tohoku Journal of Experimental Medicine|February 21, 2017
Bach2 Controls Homeostasis of Eosinophils by Restricting the Type-2 Helper Function of T CellsYuki Sato, Hiroki Kato, Risa Ebina-Shibuya, et al.
Journal of Thoracic Disease|February 11, 2021
Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trialsRisa Ebina-Shibuya, Ho Namkoong, Nobuyuki Horita, et al.
Translational Lung Cancer Research|June 24, 2021
Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trialsHiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, et al.
Respiratory Investigation|December 25, 2022
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatmentDaisuke Narita, Risa Ebina-Shibuya, Eisaku Miyauchi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Respiratory Investigation|March 22, 2023
Reply to letter to the editor "antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment"Daisuke Narita, Risa Ebina-Shibuya
Nature Reviews. Immunology|June 1, 2022
Role of thymic stromal lymphopoietin in allergy and beyondRisa Ebina-Shibuya, Warren J Leonard
Clinical and Translational Medicine|May 11, 2023
TSLP-targeting therapy: Beyond allergy?Risa Ebina-Shibuya, Warren J Leonard
Nature Reviews. Immunology|September 24, 2024
Publisher Correction: Role of thymic stromal lymphopoietin in allergy and beyondRisa Ebina-Shibuya, Warren J Leonard
Respirology (Carlton, Vic.)|June 20, 2020
National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, et al.
Clinical and Experimental Vaccine Research|September 1, 2020
Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019Risa Ebina-Shibuya, Nobuyuki Horita, Ho Namkoong, et al.
The Tohoku Journal of Experimental Medicine|February 21, 2017
Bach2 Controls Homeostasis of Eosinophils by Restricting the Type-2 Helper Function of T CellsYuki Sato, Hiroki Kato, Risa Ebina-Shibuya, et al.
Journal of Thoracic Disease|February 11, 2021
Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trialsRisa Ebina-Shibuya, Ho Namkoong, Nobuyuki Horita, et al.
Translational Lung Cancer Research|June 24, 2021
Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trialsHiromi Matsumoto, Nobuyuki Horita, Kentaro Ito, et al.
Respiratory Investigation|December 25, 2022
Antibody responses to second doses of COVID-19 vaccination in lung cancer patients undergoing treatmentDaisuke Narita, Risa Ebina-Shibuya, Eisaku Miyauchi, et al.
Pageof 3